Skip to main content
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest

Etiology Analysis of Chronic Cough After COVID-19 Infection and Research on the Efficacy of ICS or ICS/LABA

  • Read more about Etiology Analysis of Chronic Cough After COVID-19 Infection and Research on the Efficacy of ICS or ICS/LABA

COVID-19 and Intestinal Microbiota in Children

  • Read more about COVID-19 and Intestinal Microbiota in Children

Improving Attention in Individuals With Long COVID-19

  • Read more about Improving Attention in Individuals With Long COVID-19

A Comparison of Early Outcome of Surgical Management of Proximal Humerus Fracture in Adults During COVID-19 Pandemic- A Prospective Cohort Study

  • Read more about A Comparison of Early Outcome of Surgical Management of Proximal Humerus Fracture in Adults During COVID-19 Pandemic- A Prospective Cohort Study

Addressing COVID-19 Vaccine Hesitancy With Muliti-Level Interventions in Appalachia

  • Read more about Addressing COVID-19 Vaccine Hesitancy With Muliti-Level Interventions in Appalachia

Dose-Escalating Study of Pfs230D1 in Combination With R21 in Matrix-M in African Adults

  • Read more about Dose-Escalating Study of Pfs230D1 in Combination With R21 in Matrix-M in African Adults

A Clinical Study to Investigate the Safety and Immunogenicity in Relation to Product Attributes of mRNA-1083 (Severe Acute Respiratory Syndrome Coronavirus 2 [SARS-CoV-2] and Influenza Vaccine)

  • Read more about A Clinical Study to Investigate the Safety and Immunogenicity in Relation to Product Attributes of mRNA-1083 (Severe Acute Respiratory Syndrome Coronavirus 2 [SARS-CoV-2] and Influenza Vaccine)

AK117 (Anti-CD47) + Anti-EGFR for R/M HNSCC

  • Read more about AK117 (Anti-CD47) + Anti-EGFR for R/M HNSCC

Lumbrokinase for Adults With Long Covid, Post-treatment Lyme Disease Syndrome, and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

  • Read more about Lumbrokinase for Adults With Long Covid, Post-treatment Lyme Disease Syndrome, and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

Antiviral Clinical Trial for Long Covid-19

  • Read more about Antiviral Clinical Trial for Long Covid-19

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 31
  • Page 32
  • Page 33
  • Page 34
  • Current page 35
  • Page 36
  • Page 37
  • Page 38
  • Page 39
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
navigator@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA